PMC:7172841 / 9351-9701 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T40","span":{"begin":194,"end":197},"obj":"Body_part"},{"id":"T41","span":{"begin":219,"end":228},"obj":"Body_part"}],"attributes":[{"id":"A40","pred":"fma_id","subj":"T40","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma62864"}],"text":"Immune classification of patients with SARS-CoV-2 was performed by using the tools suggested for bacterial sepsis, i.e., ferritin more than 4,420 ng/mL for MAS (Kyriazopoulou et al., 2017), and HLA-DR molecules on CD14 monocytes lower than 5,000, in the absence of elevated ferritin, for the immune dysregulation phenotype (Lukaszewicz et al., 2009)."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T91","span":{"begin":39,"end":47},"obj":"Disease"},{"id":"T92","span":{"begin":39,"end":43},"obj":"Disease"},{"id":"T93","span":{"begin":97,"end":113},"obj":"Disease"},{"id":"T94","span":{"begin":156,"end":159},"obj":"Disease"}],"attributes":[{"id":"A91","pred":"mondo_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A92","pred":"mondo_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A93","pred":"mondo_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/MONDO_0005229"},{"id":"A94","pred":"mondo_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"Immune classification of patients with SARS-CoV-2 was performed by using the tools suggested for bacterial sepsis, i.e., ferritin more than 4,420 ng/mL for MAS (Kyriazopoulou et al., 2017), and HLA-DR molecules on CD14 monocytes lower than 5,000, in the absence of elevated ferritin, for the immune dysregulation phenotype (Lukaszewicz et al., 2009)."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T59","span":{"begin":219,"end":228},"obj":"http://purl.obolibrary.org/obo/CL_0000576"}],"text":"Immune classification of patients with SARS-CoV-2 was performed by using the tools suggested for bacterial sepsis, i.e., ferritin more than 4,420 ng/mL for MAS (Kyriazopoulou et al., 2017), and HLA-DR molecules on CD14 monocytes lower than 5,000, in the absence of elevated ferritin, for the immune dysregulation phenotype (Lukaszewicz et al., 2009)."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T44","span":{"begin":198,"end":200},"obj":"Chemical"},{"id":"T45","span":{"begin":201,"end":210},"obj":"Chemical"}],"attributes":[{"id":"A44","pred":"chebi_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"}],"text":"Immune classification of patients with SARS-CoV-2 was performed by using the tools suggested for bacterial sepsis, i.e., ferritin more than 4,420 ng/mL for MAS (Kyriazopoulou et al., 2017), and HLA-DR molecules on CD14 monocytes lower than 5,000, in the absence of elevated ferritin, for the immune dysregulation phenotype (Lukaszewicz et al., 2009)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T76","span":{"begin":0,"end":350},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Immune classification of patients with SARS-CoV-2 was performed by using the tools suggested for bacterial sepsis, i.e., ferritin more than 4,420 ng/mL for MAS (Kyriazopoulou et al., 2017), and HLA-DR molecules on CD14 monocytes lower than 5,000, in the absence of elevated ferritin, for the immune dysregulation phenotype (Lukaszewicz et al., 2009)."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T42","span":{"begin":107,"end":113},"obj":"Phenotype"},{"id":"T43","span":{"begin":292,"end":312},"obj":"Phenotype"}],"attributes":[{"id":"A42","pred":"hp_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/HP_0100806"},{"id":"A43","pred":"hp_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/HP_0002958"}],"text":"Immune classification of patients with SARS-CoV-2 was performed by using the tools suggested for bacterial sepsis, i.e., ferritin more than 4,420 ng/mL for MAS (Kyriazopoulou et al., 2017), and HLA-DR molecules on CD14 monocytes lower than 5,000, in the absence of elevated ferritin, for the immune dysregulation phenotype (Lukaszewicz et al., 2009)."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T165","span":{"begin":39,"end":49},"obj":"SP_7"},{"id":"T166","span":{"begin":97,"end":106},"obj":"NCBITaxon:2"},{"id":"T167","span":{"begin":194,"end":197},"obj":"PR:000029150"},{"id":"T168","span":{"begin":201,"end":210},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T169","span":{"begin":214,"end":218},"obj":"PR:000001889"},{"id":"T170","span":{"begin":219,"end":228},"obj":"CL:0000576"},{"id":"T171","span":{"begin":292,"end":298},"obj":"UBERON:0002405"},{"id":"T172","span":{"begin":299,"end":312},"obj":"GO:0065007"},{"id":"T2298","span":{"begin":24,"end":33},"obj":"NCBITaxon:7719"},{"id":"T63395","span":{"begin":34,"end":39},"obj":"NCBITaxon:10239"},{"id":"T93033","span":{"begin":73,"end":81},"obj":"SP_7"},{"id":"T14745","span":{"begin":97,"end":105},"obj":"SP_7"},{"id":"T59526","span":{"begin":144,"end":149},"obj":"UBERON:0002405;GO:0006955"},{"id":"T58621","span":{"begin":150,"end":160},"obj":"GO:0042110"},{"id":"T18082","span":{"begin":176,"end":189},"obj":"GO:0065007"},{"id":"T29233","span":{"begin":228,"end":231},"obj":"PR:000001004"},{"id":"T34864","span":{"begin":232,"end":236},"obj":"PR:000001006"},{"id":"T94440","span":{"begin":238,"end":249},"obj":"CL:0000542"},{"id":"T36159","span":{"begin":263,"end":267},"obj":"PR:000001006"},{"id":"T68934","span":{"begin":269,"end":280},"obj":"CL:0000542"},{"id":"T98249","span":{"begin":290,"end":294},"obj":"PR:000001483"},{"id":"T23756","span":{"begin":296,"end":300},"obj":"PR:000001024"},{"id":"T95024","span":{"begin":301,"end":305},"obj":"PR:000001006"},{"id":"T10452","span":{"begin":307,"end":318},"obj":"CL:0000542"},{"id":"T64864","span":{"begin":328,"end":332},"obj":"PR:000001483"},{"id":"T34718","span":{"begin":333,"end":337},"obj":"PR:000001024"},{"id":"T36171","span":{"begin":338,"end":342},"obj":"PR:000001006"}],"text":"Immune classification of patients with SARS-CoV-2 was performed by using the tools suggested for bacterial sepsis, i.e., ferritin more than 4,420 ng/mL for MAS (Kyriazopoulou et al., 2017), and HLA-DR molecules on CD14 monocytes lower than 5,000, in the absence of elevated ferritin, for the immune dysregulation phenotype (Lukaszewicz et al., 2009)."}

    2_test

    {"project":"2_test","denotations":[{"id":"32320677-28918754-19656934","span":{"begin":183,"end":187},"obj":"28918754"},{"id":"32320677-19707128-19656935","span":{"begin":344,"end":348},"obj":"19707128"}],"text":"Immune classification of patients with SARS-CoV-2 was performed by using the tools suggested for bacterial sepsis, i.e., ferritin more than 4,420 ng/mL for MAS (Kyriazopoulou et al., 2017), and HLA-DR molecules on CD14 monocytes lower than 5,000, in the absence of elevated ferritin, for the immune dysregulation phenotype (Lukaszewicz et al., 2009)."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"355","span":{"begin":214,"end":218},"obj":"Gene"},{"id":"356","span":{"begin":25,"end":33},"obj":"Species"},{"id":"357","span":{"begin":39,"end":49},"obj":"Species"},{"id":"361","span":{"begin":97,"end":113},"obj":"Disease"}],"attributes":[{"id":"A355","pred":"tao:has_database_id","subj":"355","obj":"Gene:929"},{"id":"A356","pred":"tao:has_database_id","subj":"356","obj":"Tax:9606"},{"id":"A357","pred":"tao:has_database_id","subj":"357","obj":"Tax:2697049"},{"id":"A361","pred":"tao:has_database_id","subj":"361","obj":"MESH:D016920"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Immune classification of patients with SARS-CoV-2 was performed by using the tools suggested for bacterial sepsis, i.e., ferritin more than 4,420 ng/mL for MAS (Kyriazopoulou et al., 2017), and HLA-DR molecules on CD14 monocytes lower than 5,000, in the absence of elevated ferritin, for the immune dysregulation phenotype (Lukaszewicz et al., 2009)."}